Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1 091,51
-2,30
-0,21%
—1 093,811 096,521 100,221 091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1 237,98
-16,83
-1,34%
—1 254,811 253,011 253,871 226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1 744,71
-16,40
-0,93%
—1 761,111 764,271 766,881 744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3 260,69
+48,86
+1,52%
—3 211,833 227,213 268,383 226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1 466,80
-7,72
-0,52%
—1 474,521 479,031 481,041 466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2 397,50
+5,38
+0,22%
—2 392,122 396,952 421,222 382,32——
DPHARMA:KLSE
Duopharma Biotech Bhd
MYR 1,28
-0,78%
(-0,0100) 1D
30 Apr., 17:00:00 GMT+8  ·   MYR
All symbols
SymbolPriceChange% Change
Generating top insights for DPHARMA...
Open
MYR 1,29
High
MYR 1,29
Low
MYR 1,28
Mkt. cap
1,23 mjd
Avg. vol.
468,60 k
Volume
119,30 k
Dividend
3,55%
Quarterly dividend
MYR 0,01
Ex dividend date
12 Mrt. 2026
P/E ratio
14,08
52-wk high
MYR 1,57
52-wk low
MYR 1,19
EPS
MYR 0,09
Shares outstanding
961,94 m
No. of employees
2 k
News stories
From sources across the web
About Duopharma Biotech Bhd
CEO-
Employees2 k
Founded1978
Headquarters-
SectorPharmaceutical industry
Websiteduopharmabiotech.com
Previous reportsAll values in MYR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in MYR
Mrt. 2025
Jun. 2025
Sep. 2025
Des. 2025
Revenue
262,74 m
221,78 m
222,49 m
224,69 m
Cost of goods sold
169,45 m
138,73 m
131,74 m
128,63 m
Cost of revenue
169,45 m
138,73 m
131,74 m
128,63 m
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
54,76 m
51,42 m
56,11 m
64,37 m
Operating expense
54,70 m
51,57 m
56,18 m
66,90 m
Total operating expenses
224,15 m
190,30 m
187,93 m
195,53 m
Operating income
38,58 m
31,48 m
34,56 m
29,15 m
Other non operating income
-
-
-
-590,00 k
EBT including unusual items
33,74 m
26,58 m
29,68 m
24,91 m
EBT excluding unusual items
33,74 m
26,58 m
29,68 m
24,90 m
Income tax expense
8,10 m
6,38 m
7,11 m
5,86 m
Effective tax rate
24,00%
24,00%
23,96%
23,52%
Other operating expenses
-53,00 k
154,00 k
76,00 k
2,00 m
Net income
25,64 m
20,20 m
22,57 m
19,05 m
Net profit margin
9,76%
9,11%
10,14%
8,48%
Earnings per share
-
-
-
-
Interest and investment income
1,40 m
1,42 m
1,53 m
1,52 m
Interest expense
-6,25 m
-6,32 m
-6,40 m
-5,19 m
Net interest expenses
-4,85 m
-4,90 m
-4,88 m
-3,67 m
Depreciation and amortization charges
-
-
-
-
EBITDA
49,82 m
42,88 m
45,74 m
32,61 m
Gain or loss from assets sale
-
-10,00 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer